Renal dysfunction as a consequence of acute liver damage by bile duct ligation in cirrhotic rats

Experimental and Toxicologic Pathology

Volumn 58, Issue 2-3, 2006, Pages 185-195

  Rivera Huizar, Sandra ^a   Rincón Sánchez, Ana Rosa ^a   Covarrubias Pinedo, Amador ^b   Islas Carbajal, María Cristina ^a   Gabriel Ortíz, Genaro ^c   Pedraza Chaverrí, José ^d   Álvarez Rodríguez, Adriana ^a   Meza García, Eduardo ^a   Armendáriz Borunda, Juan ^a,e  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b Unit of Clinical Investigation OPD Civil Hospital Juan I Menchaca   (Mexico)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e OPD Civil Hospital of Guadalajara   (Mexico)

Author keywords

Bile duct ligation; Cirrhosis; Hepato renal syndrome; Renal damage

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CREATININE; NITROGEN; RENIN; SODIUM;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXPERIMENTAL MODEL; GLOMERULUS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HYPERBILIRUBINEMIA; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY TUBULE NECROSIS; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER INJURY; MALE; MESANGIUM CELL; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PORTAL VEIN; RAT; SODIUM URINE LEVEL; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

EID: 33750314611     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2006.05.001     Document Type: Article

References (33)

1. Allison M.E., Moss N.G., Fraser M.M., et al. Renal function in chronic obstructive jaundice: a micropuncture study in rats. Clin Sci Mol Med 54 (1978) 649-659
2. Arroyo V., Ginés P., Gerbes A.L., et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23 (1996) 164-176
3. Arroyo V., Guevara M., and Gines P. Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology 122 (2002) 1658-1676
4. Barada K. Hepatorenal syndrome: pathogenesis and novel pharmacological targets. Curr Opin Pharmacol 4 (2004) 189-197
5. Better O.S., and Massry S.G. Effect of chronic bile duct obstruction on renal handling of salt and water. J Clin Invest 51 (1972) 402-411
6. Bosch J., Enriquez R., Groszmann J.R., and Storer H.E. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model. Hepatology 3 (1983) 1002-1007
7. Briglia A.E., and Anania F.A. Hepatorenal syndrome. Definition, pathophysiology, and intervention. Crit Care Clin 18 (2002) 345-373
8. Cardenas A., Gines P., and Rodes J. Renal complications. In: Schiff R., Sorrell M., and Maddrey W. (Eds). Diseases of the liver, vol. 1. 9th ed (2003), Lippincott Williams & Wilkins, Philadelphia 497-509
9. Ehrinpreis M.N., Giambrone M.A., and Rojkind M. Liver proline oxidase activity and collagen synthesis in rats with cirrhosis induced by carbon tetrachloride. Biochim Biophys Acta 629 (1980) 184-193
10. Ginés A., Escorsell A., Ginés P., et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105 (1993) 229-236
11. Gines P., Guevara M., Arroyo V., and Rodes J. Hepatorenal syndrome. Lancet 362 (2003) 1819-1827
12. Ibarra-Rubio M.E., Cruz C., Tapia E., Peña J.C., and Pedraza-Chaverri J. Serum angiotensin converting activity and plasma renin activity in experimental models of rats. Clin Exp Pharmacol Physiol 17 (1990) 391-399
13. Islas-Carbajal M.C., Covarrubias A., Grijalva G., Alvarez A., Armendáriz-Borunda J., and Rincón-Sánchez A.R. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Liver Int 25 (2005) 131-140
14. Jeyarajah D.R., Kielar M.L., Zhou X.J., Zhang Y., and Lu C.Y. Acute bile duct ligation ameliorates ischemic renal failure. Nephron Physiol 95 (2003) 28-35
15. Jin B., Alter H.J., Zhang Z.C., et al. Reversibility of experimental rabbit liver cirrhosis by portal collagenase administration. Lab Invest 85 (2005) 992-1002
16. Kountouras J., Billing B.H., and Scheuer P.J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 65 (1984) 305-311
17. Lancestremere R.G., Davidson P.L., Earley L.E., et al. Renal failure in Laennec's cirrhosis II. Simultaneous determination of cardiac output and renal hemodynamics. J Clin Invest 41 (1962) 1922-1927
18. Lee S.S., Girod C., Braillon A., et al. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am J Physiol 251 (1986) G176-G180
19. Lieberman F.L., Ito S., and Reynolds T.B. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a spontaneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis. J Clin Invest 48 (1969) 975-981
20. Liu Y., Binz J., Numerick M.J., et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 112 (2003) 1678-1687
21. Mayoral P., Criado M., Hidalgo F., et al. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation. Clin Sci 96 (1999) 297-305
22. Monasterolo L.A., Ochoa J.E., and Elias M.M. Rat renal function four days after bile-duct ligation: effects of indomethacin and vasoactive agents. Ren Fail 24 (2002) 111-126
23. Oberti F., Pilette C., Rifflet H., et al. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol 26 (1997) 1363-1371
24. Poo J.L., Estanes A., Pedraza-Chaverrí J., et al. Chronology of portal hypertension, decreased sodium excretion, and activation of the rennin-angiotensin system in experimental biliary cirrhosis. Rev Invest Clin 49 (1997) 15-23
25. Rincón A.R., Covarrubias A., Rivera S.V., et al. Differential effect of CCl4 on renal function and structure of cirrhotic and non-cirrhotic rats. Hepatology 26 (1997) 234A
26. Rincón A.R., Covarrubias A., Pedraza-Chaverrí J., et al. Differential effect of CCl4 on renal function in cirrhotic and non-cirrhotic rats. Exp Toxicol Pathol 51 (1999) 199-205
27. Rodriguez-Garay E.A. Cholestasis: human disease and experimental animal models. Ann Hepatol 2 (2003) 150-158
28. Schaffner F., Bacchin P.G., Hutterer F., et al. Mechanism of cholestasis. 4. Structural and biochemical changes in the liver and serum in rats after bile duct ligation. Gastroenterology 60 (1971) 888-897
29. Shasha S.M., Better O.S., Chaimovitz C., et al. Haemodynamic studies in dogs with chronic bile-duct ligation. Clin Sci Mol Med 50 (1976) 533-537
30. Singh S., Shackleton G., Ah-Sing E., Chakraborty J., and Bailey M.E. Antioxidant defenses in the bile duct-ligated rat. Gastroenterology 103 (1992) 1625-1629
31. Tokuyama H., Hayashi K., Matsuda H., et al. Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia. Am J Physiol Renal Physiol 282 (2002) F859-F865
32. Wang L. Plasma volume, cell volume, total blood volume and F cells factor in the normal and splenectomized Sherman rat. Am J Physiol 196 (1959) 188-192
33. Wensing G., Sabra R., and Branch R.A. The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function. Hepatology 11 (1990) 779-786